Introduction
Restriction landmark genomic scanning (RLGS) is a method which allows the detection of genetic differences between two DNA samples. It is based on the endlabeling of rare cutting restriction sites and the separation of these fragments by two-dimensional gel electrophoresis. 1 RLGS profiles display over 2000 fragments, or "spots," having intensities which correlate with the copy number of the particular sequence. Most of the rare cutting restriction enzymes used in RLGS possess GC-rich recognition sequences that are mainly found in CpG-islands in mammalian genomes. CpG islands are located in the 5' regulatory regions of all known housekeeping genes and 40% of tissue-specific genes.
2 ' 3 Thus, RLGS profiles are strongly biased towards the display of sequences located in the vicinity of genes, rather than random genomic DNA fragments. In humans, RLGS has been used by several groups for the detection of genetic and epigenetic changes which accompany human tumorigenesis. 4 ' 5 An essential step in RLGS analysis is the cloning of DNA sequences corresponding to RLGS spots in order to identify genes affected by the specific alteration. Several RLGS spot cloning procedures have been described and are based on either a restriction trapper purification of genomic DNA to reduce the amount of unlabeled background fragments, 6 or involve the ligation of adaptor sequences to the ends of the spot DNA followed by polymerase chain reaction (PCR), 7 or a combination of the two methods. 5 However, the size of RLGS spot clones In order to provide rapid access to such intermediatesized clones, we generated a Not I-EcoRV library as a resource to facilitate the analysis of RLGS loci. A plasmid vector was selected for the cloning to generate a cloning bias towards smaller insert sizes of 0.5-10 kbp; the size range separated in the 1st dimension of the RLGS. Five hundred /ig of peripheral blood lymphocyte DNA (PBL) from a female donor was digested with Not I and EcoBV and the resulting fragments were purified using the Not I restriction trapper method. 8 This purification step greatly reduces the amount of ECOBLV-ECORV fragments by using Not I restriction digestion to selectively release the Not I-EcoBV fragments from the Not I restriction trapper. 8 The genomic fragments were ligated into the pBluescript KS vector and cloned in the DH10B competent Escherichia coli. According to blue/white selection, 8.5% of the clones were non-recombinant. Insert sizes of 100 randomly picked recombinant clones ranged from 0.4 kbp to 20 kbp with a mean insert size of 3.7 kbp. This size range covers the molecular weight of restriction fragments separated in the 1st dimension of the RLGS 9 Neglecting the rare possibility of two Not I sites in a CpG island separated by a sequence without an .EcoRV site, the library thus has an approximately 7.6-fold coverage. However, plasmids with smaller inserts have a better transforming efficiency and prevail over those with large inserts. We have found that approximately 29% of the Not I-EcoKV fragments are greater than 12 kbp (see below). Thus, it is estimated that this library covers approximately 71% of the total Not I-.EcoRV fragments in the human genome and contains most or all of the Not I-EcoBV fragments relevant to the DNA fragments present in the RLGS profiles of the Not 1-EcoRV-Hintt digested DNA.
A screen was performed to identify upstream and downstream (relative to the Not I site) Not I-EcoKV fragments from seven known cancer genes: the 5' region of the Wilms' tumor suppressor gene (WT), c-Myc, the estrogen receptor gene (ESR), the CDK inhibitor pl9INK4d, the fibroblastic growth factor type 4 (FGF4), FES and the von Hippel-Lindau tumor suppressor gene (VHL). All selected genes have a Not I restriction site in the gene or promoter sequence. The result of the screen is summarized in Table 1 . A total of 11 independent WT clones were identified in the complete library. Six clones were tested and found to contain the same 2.3-kbp Not IEcoBV insert. Sequencing of the insert ends confirmed that these clones represent the upstream region of the WT gene. Both upstream and downstream Not I-EcoRV fragments were identified only for pl9INK4d, whereas only one, either the upstream or downstream clone, was identified for WT, FGF4, c-Myc, and ESR (see Table 1 ). Clones were not identified for VHL and FES. The absence of these clones suggests that the Not 1-EcoKV fragments are too large and thus not represented in this library.
The screening indicated that the likelihood of obtaining both upstream and downstream Not I-EcoRV fragments is small. This is clearly indicated in the case of the WT gene since the 2.3-kbp upstream Not I-EcoKV fragment was isolated from the library, whereas the downstream fragment was not. Subsequent Southern blot analysis revealed that the downstream Not I-EcoKV fragment of the WT locus is >25 kbp, and would therefore not be expected to be efficiently cloned into our library. We have measured the size distribution of genomic Not 1-EcoRV fragments in a 60 cm 0.8% agarose disc gel and found that, in fact, approximately 29% of all Not 1-EcoBV fragments are over 12 kbp (data not shown). These larger fragments are too large to be efficiently cloned into a plasmid vector and thus will be under-represented or absent in the library (see above). In addition, there is a possibility that two Not I restriction sites occur in the same CpG island. If no .EcoRV site is present between these two sites, the resultant Not I-Not I fragment would not be present in the library. This situation results in the exclusion of many rDNA sequences from our Not I-EcoRV library since these sequences are very GC-rich and possess a number of small Not l-Not I fragments which lack internal EcoEV restriction sites. 10 Heterozygosity for a restriction enzyme polymorphism (Not I or EcoKV) in the PBL DNA may generate additional clones. For example, in the screen with the ESR gene we obtained clones with both 2.8 kbp and 3.6 kbp insert sizes. Restriction mapping and sequencing of the insert ends showed that both clones shared the upstream part of the Not I site, indicating that the donor DNA likely had an EcoEV polymorphism. The downstream clone for ESR is not contained in the library.
The Not 1-EcoRV clones can be used to identify RLGS spots corresponding to known genes. For RLGS analysis of genetic alterations in human tumor samples, it would be desirable to have spots identified which correspond to genes known to be involved in the progression of the particular tumor type. Thus, a single RLGS gel could provide information on possible genetic alterations at several known loci involved in tumorigenesis. Known gene sequences could be isolated from the library, and these Not 1-EcoEV clones could then be used in mixing experiments to identify the corresponding RLGS spot. Once RLGS spots are correlated with known genes, changes in these genes can be immediately identified in multiple tumor samples. Of major interest are spots corresponding to tumor suppressor genes or genes known to be amplified in tumors. The presence and/or copy number of these spots can be determined for each available RLGS profile once these spots are identified. Furthermore, as DNA methylation in the promoter regions of tumor suppressor genes has been identified in several cases as a mechanism for gene silencing, it is important to note that the RLGS technique is well suited to detect changes in methylation status.
The library can also be used to confirm that the DNA fragment isolated from the cloning procedure is in fact derived from the intended spot, rather than a nearby but irrelevant spot. This can be accomplished by identifying a corresponding Not 1-EcoTW boundary clone and mixing the DNA of this clone with total genomic DNA to enhance the spot of interest approximately tenfold.
The small size of the library makes the handling and distribution of plates and filters to other laboratories relatively easy. The protocol which was used to establish the library can be easily adapted for the preparation of additional boundary libraries with different landmark enzymes (e.g. Asc I). Over time, data about clone locations will accumulate from different laboratories using this library. For example, a spot which was amplified in human gliomas was cloned and identified as CDK6. 9 Thus, the spot position for the CDK6 gene is known as well as the location on chromosome 7.
